The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model

View More View Less
  • 1 Departments of Neurosurgery, Biochemistry, Molecular Biology, and Immunology, University of Southern California, Keck School of Medicine; and K. Norris Jr. Comprehensive Cancer Center, Los Angeles, California
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object

Malignant gliomas are not curable because of diffuse brain invasion. The tumor cells invade the surrounding brain tissue without a clear tumor—brain demarcation line, making complete resection impossible. Therapy aimed at inhibition of invasion is crucial not only for prevention of tumor spread, but also for selectively blocking migrating cells that may be more resistant to chemotherapy and radiation. Recently, investigations have shown that the snake venom disintegrin contortrostatin specifically binds to certain integrins on the surface of glioma cells and thereby inhibits their interaction with the extracellular matrix (ECM), resulting in a blockage of cell motility and invasiveness. To translate these in vitro findings into clinical settings, the authors examined the effect of contortrostatin on glioma progression in a rodent model.

Methods

Athymic mice were intracranially or subcutaneously injected with U87 glioma cells, and the effect of intratumorally administered contortrostatin on tumor progression and animal survival was then studied. In addition, the authors evaluated the pharmacological safety of contortrostatin use in the brains of tumor-free animals.

Conclusions

The results demonstrate that contortrostatin is able to inhibit tumor growth and angiogenesis and to prolong survival in a rodent glioma model. Moreover, contortrostatin appears to be well tolerated by the animal and lacks obvious neurotoxic side effects. Thus, contortrostatin may have potential as a novel therapeutic agent for the treatment of malignant gliomas.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1.

    Albers P, , Orazi A, , Ulbright TM, , Miller GA, , Haidar JH, & Donohue JP, et al: Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod Pathol 8:492497, 1995 Albers P, Orazi A, Ulbright TM, Miller GA, Haidar JH, Donohue JP, et al: Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod Pathol 8:492–497, 1995

    • Search Google Scholar
    • Export Citation
  • 2.

    Alving CR: Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187:430446, 1993 Alving CR: Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187:430–446, 1993

    • Search Google Scholar
    • Export Citation
  • 3.

    Arvanitis DL, , Stavridou AI, , Mori de Moro G, & Szuchet S: Reactive astrocytes upregulate one or more gene products that are recognized by monoclonal antibody H. Cell Tissue Res 304:1119, 2001 Arvanitis DL, Stavridou AI, Mori de Moro G, Szuchet S: Reactive astrocytes upregulate one or more gene products that are recognized by monoclonal antibody H. Cell Tissue Res 304:11–19, 2001

    • Search Google Scholar
    • Export Citation
  • 4.

    Bello L, , Francolini M, , Marthyn P, , Zhang J, , Carroll RS, & Nikas DC, et al: Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49:380390, 2001 Bello L, Francolini M, Marthyn P, Zhang J, Carroll RS, Nikas DC, et al: Alpha(v)beta3 and alpha(v)beta5 integrin expression in glioma periphery. Neurosurgery 49:380–390, 2001

    • Search Google Scholar
    • Export Citation
  • 5.

    Brooks PC, , Clark RA, & Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569571, 1994 Brooks PC, Clark RA, Cheresh DA: Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264:569–571, 1994

    • Search Google Scholar
    • Export Citation
  • 6.

    Cao Y: Antiangiogenic cancer therapy. Semin Cancer Biol 14:139145, 2004 Cao Y: Antiangiogenic cancer therapy. Semin Cancer Biol 14:139–145, 2004

    • Search Google Scholar
    • Export Citation
  • 7.

    Chen N, , Leu SJ, , Todorovic V, , Lam SC, & Lau LF: Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells. J Biol Chem 279:4416644176, 2004 Chen N, Leu SJ, Todorovic V, Lam SC, Lau LF: Identification of a Novel Integrin {alpha}v{beta}3 Binding Site in CCN1 (CYR61) Critical for Pro-angiogenic Activities in Vascular Endothelial Cells. J Biol Chem 279:44166–44176, 2004

    • Search Google Scholar
    • Export Citation
  • 8.

    Cokgor I, , Akabani G, , Kuan C, , Friedman HS, , Friedman AH, & Coleman RE, et al: Phase I trial results of iodine-131 labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. J Clin Oncol 18:38623872, 2000 Cokgor I, Akabani G, Kuan C, Friedman HS, Friedman AH, Coleman RE, et al: Phase I trial results of iodine-131 labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. J Clin Oncol 18:3862–3872, 2000

    • Search Google Scholar
    • Export Citation
  • 9.

    Dejana E, , Lampugnani MG, , Martinez-Estrada O, & Bazzoni G: The molecular organization of endothelial junctions and their function role in vascular morphogenesis and permeability. Int J Dev Biol 44:743748, 2000 Dejana E, Lampugnani MG, Martinez-Estrada O, Bazzoni G: The molecular organization of endothelial junctions and their function role in vascular morphogenesis and permeability. Int J Dev Biol 44:743–748, 2000

    • Search Google Scholar
    • Export Citation
  • 10.

    Duchrow M, , Gerdes J, & Schluter C: The proliferation-associated Ki-67 protein: definition in molecular terms. Cell Prolif 27:235242, 1994 Duchrow M, Gerdes J, Schluter C: The proliferation-associated Ki-67 protein: definition in molecular terms. Cell Prolif 27:235–242, 1994

    • Search Google Scholar
    • Export Citation
  • 11.

    Eng LF, , Ghirnikar RS, & Lee YL: Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:14391451, 2000 Eng LF, Ghirnikar RS, Lee YL: Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25:1439–1451, 2000

    • Search Google Scholar
    • Export Citation
  • 12.

    Federici AB: The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica 88: EREP02, 2003 Federici AB: The factor VIII/von Willebrand factor complex: basic and clinical issues. Haematologica 88: EREP02, 2003

    • Search Google Scholar
    • Export Citation
  • 13.

    Filipkowski RK, , Hetman M, , Kaminska B, & Kaczmarek L: DNA fragmentation in rat brain after itraperitoneal administration of kainate. Neuroreport 5:15381540, 1994 Filipkowski RK, Hetman M, Kaminska B, Kaczmarek L: DNA fragmentation in rat brain after itraperitoneal administration of kainate. Neuroreport 5:1538–1540, 1994

    • Search Google Scholar
    • Export Citation
  • 14.

    Friedl P: Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 16:1423, 2004 Friedl P: Prespecification and plasticity: shifting mechanisms of cell migration. Curr Opin Cell Biol 16:14–23, 2004

    • Search Google Scholar
    • Export Citation
  • 15.

    Gavrieli Y, , Sherman Y, & Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of muclear fragmentation. J Cell Biol 119:493501, 1992 Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of muclear fragmentation. J Cell Biol 119:493–501, 1992

    • Search Google Scholar
    • Export Citation
  • 16.

    Giancotti FG: A structural view of integrin activation and signaling. Dev Cell 4:149151, 2003 Giancotti FG: A structural view of integrin activation and signaling. Dev Cell 4:149–151, 2003

    • Search Google Scholar
    • Export Citation
  • 17.

    Giles GG, & Gonzales MF: Epidemiology of brain tumors and factors in prognosis, in Kaye AH, & Laws ER Jr (eds): Brain Tumors. An Encyclopedic Approach, ed 2. London: Churchill Livingstone, 2001 pp 5170 Giles GG, Gonzales MF: Epidemiology of brain tumors and factors in prognosis, in Kaye AH, Laws ER Jr (eds): Brain Tumors. An Encyclopedic Approach, ed 2. London: Churchill Livingstone, 2001 pp 51–70

    • Search Google Scholar
    • Export Citation
  • 18.

    Gladson CL: Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 55:11431149, 1996 Gladson CL: Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropathol Exp Neurol 55:1143–1149, 1996

    • Search Google Scholar
    • Export Citation
  • 19.

    Gladson CL, & Cheresh DA: Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88:19241932, 1991 Gladson CL, Cheresh DA: Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88:1924–1932, 1991

    • Search Google Scholar
    • Export Citation
  • 20.

    Goldbrunner RH, , Bernstein JJ, & Tonn JC: ECM-mediated glioma cell invasion. Microsc Res Tech 43:250257, 1998 Goldbrunner RH, Bernstein JJ, Tonn JC: ECM-mediated glioma cell invasion. Microsc Res Tech 43:250–257, 1998

    • Search Google Scholar
    • Export Citation
  • 21.

    Golubkov V, , Hawes D, & Markland FS: Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom. Angiogenesis 6:213224, 2003 Golubkov V, Hawes D, Markland FS: Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom. Angiogenesis 6:213–224, 2003

    • Search Google Scholar
    • Export Citation
  • 22.

    Ikeda Y, , Carson BS, , Lauer JA, & Long DM: Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema. J Neurosurg 79:716721, 1993 Ikeda Y, Carson BS, Lauer JA, Long DM: Therapeutic effects of local delivery of dexamethasone on experimental brain tumors and peritumoral brain edema. J Neurosurg 79:716–721, 1993

    • Search Google Scholar
    • Export Citation
  • 23.

    Jansen M, , de Witt Hamer PC, , Witmer AN, , Troost D, & van Noorden CJ: Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev 45:143163, 2004 Jansen M, de Witt Hamer PC, Witmer AN, Troost D, van Noorden CJ: Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas. Brain Res Brain Res Rev 45:143–163, 2004

    • Search Google Scholar
    • Export Citation
  • 24.

    Lamborn KR, , Chang SM, & Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neurooncology 6:227235, 2004 Lamborn KR, Chang SM, Prados MD: Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neurooncology 6:227–235, 2004

    • Search Google Scholar
    • Export Citation
  • 25.

    Markland FS, , Shieh K, , Zhou Q, , Golubkov V, , Sherwin RP, & Richters V, et al: A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 31:183191, 2001 Markland FS, Shieh K, Zhou Q, Golubkov V, Sherwin RP, Richters V, et al: A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model. Haemostasis 31:183–191, 2001

    • Search Google Scholar
    • Export Citation
  • 26.

    Nagashima G, , Suzuki R, , Asai JI, , Noda M, , Fujimoto M, & Fujimoto T: Tissue reconstruction process in the area of peri-tumoral oedema caused by glioblastoma—immunohistoochemical and graphical analysis using brain obtained at biopsy. Acta Neurochir Suppl 86:507511, 1996 Nagashima G, Suzuki R, Asai JI, Noda M, Fujimoto M, Fujimoto T: Tissue reconstruction process in the area of peri-tumoral oedema caused by glioblastoma—immunohistoochemical and graphical analysis using brain obtained at biopsy. Acta Neurochir Suppl 86:507–511, 1996

    • Search Google Scholar
    • Export Citation
  • 27.

    Okazaki H, & Scheithauer BW: Atlas of Neuropathology. New York: Grower Medical Publishing, 1988 Okazaki H, Scheithauer BW: Atlas of Neuropathology. New York: Grower Medical Publishing, 1988

    • Search Google Scholar
    • Export Citation
  • 28.

    Paulus W, , Baur I, , Beutler AS, & Reeves SA: Diffuse brain invasion of glioma cells requires β1 integrins. Lab Invest 75:819826, 1996 Paulus W, Baur I, Beutler AS, Reeves SA: Diffuse brain invasion of glioma cells requires β1 integrins. Lab Invest 75:819–826, 1996

    • Search Google Scholar
    • Export Citation
  • 29.

    Remer S, & Murphy ME: The challenges of long-term treatment outcomes in adults with malignant gliomas. Clin J Oncol Nurs 8:368376, 2004 Remer S, Murphy ME: The challenges of long-term treatment outcomes in adults with malignant gliomas. Clin J Oncol Nurs 8:368–376, 2004

    • Search Google Scholar
    • Export Citation
  • 30.

    Schmitmeier S, , Markland FS, & Chen TC: Anti invasive effect of contortrostatin, a snake venom disintegrin, and TNF-α on malignant glioma cells. Anticancer Res 20:42274234, 2000 Schmitmeier S, Markland FS, Chen TC: Anti invasive effect of contortrostatin, a snake venom disintegrin, and TNF-α on malignant glioma cells. Anticancer Res 20:4227–4234, 2000

    • Search Google Scholar
    • Export Citation
  • 31.

    Schmitmeier S, , Markland FS, , Ritter MR, , Sawcer DE, & Chen TC: Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro. Cell Comm Ad 10:116, 2003 Schmitmeier S, Markland FS, Ritter MR, Sawcer DE, Chen TC: Functional effect of contortrostatin, a snake venom disintegrin, on human glioma cell invasion in vitro. Cell Comm Ad 10:1–16, 2003

    • Search Google Scholar
    • Export Citation
  • 32.

    Schmitmeier S, , Markland FS, , Schoenthal AH, & Chen TC: Potent mimicry of fibronectin-induced intracellular signalling in glioma cells by the homodimeric snake venom disintegrin contortrostatin. Neurosurgery 57:141153, 2005 Schmitmeier S, Markland FS, Schoenthal AH, Chen TC: Potent mimicry of fibronectin-induced intracellular signalling in glioma cells by the homodimeric snake venom disintegrin contortrostatin. Neurosurgery 57:141–153, 2005

    • Search Google Scholar
    • Export Citation
  • 33.

    Stromblad S, , Becker JC, , Yebra M, , Brooks PC, & Cheresh DA: Suppression of p53 activity and p21 WAF1/CIP1 expression by vascular cell integrin alpha v beta 3 during angiogenesis. J Clin Invest 98:426433, 1996 Stromblad S, Becker JC, Yebra M, Brooks PC, Cheresh DA: Suppression of p53 activity and p21 WAF1/CIP1 expression by vascular cell integrin alpha v beta 3 during angiogenesis. J Clin Invest 98:426–433, 1996

    • Search Google Scholar
    • Export Citation
  • 34.

    Swenson S, , Costa F, , Minea R, , Sherwin RP, , Ernst W, & Fujii G, et al: Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther 3:499511, 2004 Swenson S, Costa F, Minea R, Sherwin RP, Ernst W, Fujii G, et al: Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther 3:499–511, 2004

    • Search Google Scholar
    • Export Citation
  • 35.

    Trikha M, , De Clerck YA, & Markland FS: Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res 54:49934998, 1994 Trikha M, De Clerck YA, Markland FS: Contortrostatin, a snake venom disintegrin, inhibits beta 1 integrin-mediated human metastatic melanoma cell adhesion and blocks experimental metastasis. Cancer Res 54:4993–4998, 1994

    • Search Google Scholar
    • Export Citation
  • 36.

    Trikha M, , Rote WE, , Manley PJ, , Lucchesi BR, S, & Markland FS: Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb Res 73:3952, 1994 Trikha M, Rote WE, Manley PJ, Lucchesi BR, S, Markland FS: Purification and characterization of platelet aggregation inhibitors from snake venoms. Thromb Res 73:39–52, 1994

    • Search Google Scholar
    • Export Citation
  • 37.

    Uhm JH, , Gladson CL, & Rao JS: The role of integrins in the malignant phenotype of gliomas. Front Biosci 4:188199, 1999 Uhm JH, Gladson CL, Rao JS: The role of integrins in the malignant phenotype of gliomas. Front Biosci 4:188–199, 1999

    • Search Google Scholar
    • Export Citation
  • 38.

    Viola JJ, , Agbaria R, , Walbridge S, , Oshiro EM, , Johns DG, & Kelley JA, et al: In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors. Cancer Res 55:13061309, 1995 Viola JJ, Agbaria R, Walbridge S, Oshiro EM, Johns DG, Kelley JA, et al: In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors. Cancer Res 55:1306–1309, 1995

    • Search Google Scholar
    • Export Citation
  • 39.

    Yeh CH, , Peng HC, & Huang TF: Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 92:32683276, 1998 Yeh CH, Peng HC, Huang TF: Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood 92:3268–3276, 1998

    • Search Google Scholar
    • Export Citation
  • 40.

    Zhou Q, , Nakada MT, , Arnold C, , Shieh KY, & Markland FS Jr: Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis. Angiogenesis 3:259269, 1999 Zhou Q, Nakada MT, Arnold C, Shieh KY, Markland FS Jr: Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits angiogenesis. Angiogenesis 3:259–269, 1999

    • Search Google Scholar
    • Export Citation
  • 41.

    Zhou Q, , Nakada MT, , Brooks PC, , Swenson SD, , Ritter MR, & Argounova S, et al: Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5. Biochem Biophys Res Commun 267:350355, 2000 Zhou Q, Nakada MT, Brooks PC, Swenson SD, Ritter MR, Argounova S, et al: Contortrostatin, a homodimeric disintegrin, binds to integrin alphavbeta5. Biochem Biophys Res Commun 267:350–355, 2000

    • Search Google Scholar
    • Export Citation
  • 42.

    Zhou Q, , Sherwin RP, , Parrish C, , Richters V, , Groshen SG, & Tsao-Wei D, et al: Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Res Treat 61:249260, 2000 Zhou Q, Sherwin RP, Parrish C, Richters V, Groshen SG, Tsao-Wei D, et al: Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression. Breast Cancer Res Treat 61:249–260, 2000

    • Search Google Scholar
    • Export Citation
  • 43.

    Zogakis TG, & Libutti SK: General aspects of anti-angiogenesis and cancer therapy. Expert Opin Biol Ther 1:253275 Zogakis TG, Libutti SK: General aspects of anti-angiogenesis and cancer therapy. Expert Opin Biol Ther 1:253–275

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 815 269 60
Full Text Views 181 4 1
PDF Downloads 106 3 1
EPUB Downloads 0 0 0